[Federal Register Volume 64, Number 175 (Friday, September 10, 1999)]
[Notices]
[Pages 49190-49191]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-23464]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Request for Nominations for Nonvoting Representatives of Consumer 
and Industry Interests on Public Advisory Panels or Committees

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY:The Food and Drug Administration (FDA) is requesting 
nominations for nonvoting consumer representatives and nonvoting 
industry representatives to serve on certain device panels of the 
Medical Devices Advisory Committee in the Center for Devices and 
Radiological Health (CDRH). Nominations will be accepted for current 
vacancies and for those that will or may occur through July 31, 2000.
    FDA has a special interest in ensuring that women, minority groups, 
individuals with disabilities, and small businesses are adequately 
represented on advisory committees and, therefore, encourages 
nominations for appropriately qualified candidates from these groups, 
as well as nominations from small businesses that manufacture medical 
devices subject to the regulations.

DATES: Nominations should be received by October 12, 1999, for 
vacancies listed in this notice.

ADDRESSES: All nominations and curricula vitae for consumer 
representatives should be submitted in writing to Annette J. Funn 
(address below). All nominations and curricula vitae (which includes 
nominee's office address and telephone number) for industry 
representatives should be submitted in writing to Kathleen L. Walker 
(address below).

FOR FURTHER INFORMATION CONTACT: 
    Regarding consumer representatives: Annette J. Funn, Office of 
Consumer Affairs (HFE-40), Food and Drug Administration, 5600 Fishers 
Lane, Rockville, MD 20857, 301-827-4421.
    Regarding industry representatives: Kathleen L. Walker, Office of 
Systems and Management (HFZ-17), CDRH, Food and Drug Administration, 
2098 Gaither Rd., Rockville, MD 20850, 301-594-1283, ext. 114.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for nonvoting 
members representing consumer and industry interests for the vacancies 
listed below:

[[Page 49191]]



 
----------------------------------------------------------------------------------------------------------------
                                                                           Approximate Date Representative is
                                                                                         Needed
                        Medical Devices Panels                         -----------------------------------------
                                                                              Consumer             Industry
----------------------------------------------------------------------------------------------------------------
Clinical Chemistry and Clinical Toxicology Devices Panel                NV\1\..............  March 1, 2000
Dental Products Panel (Dental Drug)                                     NV\1\..............  November 1, 1999
Gastroenterology and Urology Devices Panel                              NV\1\..............  January 1, 2000
General and Plastic Surgery Devices Panel                               NV\1\..............  IMMED\2\
Hematology and Pathology Devices Panel                                  March 1, 2000......  March 1, 2000
Microbiology Devices Panel                                              NV\1\..............  March 1, 2000
Radiological Devices Panel                                              NV\1\..............  IMMED\2\
----------------------------------------------------------------------------------------------------------------
\1\ NV = No vacancy
\2\ IMMED = Immediate vacancy

I. Function

    The functions of the medical device panels are to: (1) Review and 
evaluate data on the safety and effectiveness of marketed and 
investigational devices and make recommendations for their regulation; 
(2) advise the Commissioner of Food and Drugs regarding recommended 
classification or reclassification of these devices into one of three 
regulatory categories; (3) advise on any possible risks to health 
associated with the use of devices; (4) advise on formulation of 
product development protocols; (5) review premarket approval 
applications for medical devices; (6) review guidelines and guidance 
documents; (7) recommend exemption to certain devices from the 
application of portions of the Federal Food, Drug, and Cosmetic Act 
(the act); (8) advise on the necessity to ban a device; (9) respond to 
requests from the agency to review and make recommendations on specific 
issues or problems concerning the safety and effectiveness of devices; 
and (10) make recommendations on the quality in the design of clinical 
studies regarding the safety and effectiveness of marketed and 
investigational devices.

II. Consumer and Industry Representation

    Section 520(f)(3) of the act (21 U.S.C. 360j(f)(3)), as amended by 
the Medical Device Amendments of 1976, provides that each medical 
device panel include as members one nonvoting representative of 
consumer interests and one nonvoting representative of interests of the 
medical device manufacturing industry.

III. Nomination Procedures

A. Consumer Representatives

    Any interested person may nominate one or more qualified persons as 
a member of a particular advisory committee or panel to represent 
consumer interests as identified in this notice. Self-nominations are 
also accepted. To be eligible for selection, the applicant's experience 
and/or education will be evaluated against Federal civil service 
criteria for the position to which the person will be appointed.
    Nominations shall include a complete curriculum vitae of each 
nominee and shall state that the nominee is aware of the nomination, is 
willing to serve as a member, and appears to have no conflict of 
interest that would preclude membership. FDA will ask the potential 
candidates to provide detailed information concerning such matters as 
financial holdings, employment, and research grants and/or contracts to 
permit evaluation of possible sources of conflict of interest. The 
nomination should state whether the nominee is interested only in a 
particular advisory committee or panel or in any advisory committee or 
panel. The term of office is up to 4 years, depending on the 
appointment date.

B. Industry Representatives

    Any organization in the medical device manufacturing industry 
(industry interests) wishing to participate in the selection of an 
appropriate member of a particular panel may nominate one or more 
qualified persons to represent industry interests. Persons who nominate 
themselves as industry representatives for the panels will not 
participate in the selection process. It is, therefore, recommended 
that all nominations be made by someone with an organization, trade 
association, or firm who is willing to participate in the selection 
process.
    Nominees shall be full-time employees of firms that manufacture 
products that would come before the panel, or consulting firms that 
represent manufacturers. Nominations shall include a complete 
curriculum vita of each nominee. The term of office is up to 4 years, 
depending on the appointment date.

IV. Selection Procedures

A. Consumer Representatives

    Selection of members representing consumer interests is conducted 
through procedures which include use of a consortium of consumer 
organizations which has the responsibility for recommending candidates 
for the agency's selection. Candidates should possess appropriate 
qualifications to understand and contribute to the committee's work.

B. Industry Representatives

    Regarding nominations for members representing the interests of 
industry, a letter will be sent to each person that has made a 
nomination, and to those organizations indicating an interest in 
participating in the selection process, together with a complete list 
of all such organizations and the nominees. This letter will state that 
it is the responsibility of each nominator or organization indicating 
an interest in participating in the selection process to consult with 
the others in selecting a single member representing industry interests 
for the panel within 60 days after receipt of the letter. If no 
individual is selected within 60 days, the agency will select the 
nonvoting member representing industry interests.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 30, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-23464 Filed 9-9-99; 8:45 am]
BILLING CODE 4160-01-F